AI assistant
SURMODICS INC — Director's Dealing 2020
Jan 6, 2020
32845_dirs_2020-01-06_3e75244b-3600-4026-9e6d-e0cd5c2d9e02.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: SURMODICS INC (SRDX)
CIK: 0000924717
Period of Report: 2020-01-02
Reporting Person: Maharaj Gary R (Director, President & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-01-02 | Common Stock | S | 702 | $41.0841 | Disposed | 142885 | Direct |
Footnotes
F1: Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 28, 2019.
F2: Reflects the weighted average price of 702 shares of common stock of Surmodics, Inc. sold by the reporting person in multiple transactions on January 2, 2020 with sale prices ranging from $40.77 to $41.59 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.